Happy Wednesday, Zingernation! You know how it can be difficult to gift shop for someone who seemingly has everything? Well, sometimes even the world’s wealthiest want something you can get for just $1.99 at a gas station.

–Aaron Bry and Nic Chahine

Today’s Price Action:

$SPY: +.01%
$QQQ: -.06%
$DIA: +.45%

Plus, check out the biotech company that’s cracking the code of the peripheral nervous system.

And, did someone forward you this email? Click here to subscribe to this Benzinga newsletter and more.

TODAY’S MOST VOLATILE STOCKS

TODAY’S TOP STORY

Robinhood Q1 Earnings Highlights

Briefly: Robinhood reported earnings. Here’s what you need to know.

So Basically: The retail investing platform posted record revenue of $618 million, up 40% year-over-year, beating a Street consensus estimate of $548.6 million, according to data from Benzinga Pro.

So Then: The company reported earnings per share of 18 cents in the first quarter, well above a Street consensus estimate of 5 cents per share. Gold subscribers hit a new high of 1.7 million in the first quarter, up 42% year-over-year, the fastest in quarterly growth in three years.

So What? "We continued to aggressively execute on our product roadmap in Q1, leading to all-time highs for Net Deposits and Gold Subscribers," Robinhood CEO Vlad Tenev said. Robinhood adjusted operating expenses and stock-based compensation to range from $1.85-$1.95 billion for the full year.

Click here to read more.

PRESENTED BY AUTONOMIX

Autonomix Medical (NASDAQ: AMIX) Is Cracking The Code Of The Peripheral Nervous System With Its Breakthrough Catheter-Based Sensing Technology

The peripheral nervous system (PNS) is a network of nerves that extend from the brain and spinal cord to different parts of the body. The health of the PNS plays a crucial role in nearly every disease because it is responsible for transmitting signals and information throughout the body – from cardiovascular health to chronic pain and many things in between, the PNS is essential.

While many biotechnology companies are looking to treat symptoms for various conditions, Autonomix Medical Inc. (NASDAQ: AMIX) is going to the root of the issue, which they associate with the PNS. Click here to read more about its revolutionary approach.

FIVE MOVERS

Duolingo stock tanked in after-hours trading, despite the language-learning app reporting stronger-than-expected earnings and raising guidance.

Beyond Meat shares got grilled after the close, following the company’s EPS miss.

Arm Holdings shares dropped on the semiconductor company’s report, despite beating estimates on both sales and EPS.

Uber stock dropped today because, you guessed it, an earnings report. The rideshare leader failed to impress investors by missing profit expectations.

Teva Pharmaceutical shares moved higher in today’s session after the biotech reported strong data regarding its schizophrenia drug.

ONE TRADE IDEA FOR TOMORROW

Solar Stocks Shine Again As Declining Treasury Yields Boost Market Confidence

Briefly: The Invesco Solar ETF ($TAN), which tracks the performance of approximately 40 solar energy companies, has experienced a significant upturn.

So Basically: Over the last 10 sessions, this ETF has surged by 10%, rebounding from its lowest point since July 2020.

So Then: The positive momentum is largely indebted to the decrease in long-dated U.S. Treasury yields, which have fallen substantially since late April. These declines in yields reduce the cost of borrowing and are especially beneficial for capital-intensive industries like solar energy.

So What? This rally is particularly noteworthy as it reflects broader investor optimism in the renewable energy sector.

Click here to read more.

PRESENTED BY AUTONOMIX

Autonomix Medical (NASDAQ: AMIX) Is Cracking The Code Of The Peripheral Nervous System With Its Breakthrough Catheter-Based Sensing Technology

The peripheral nervous system (PNS) is a network of nerves that extend from the brain and spinal cord to different parts of the body. The health of the PNS plays a crucial role in nearly every disease because it is responsible for transmitting signals and information throughout the body – from cardiovascular health to chronic pain and many things in between, the PNS is essential.

While many biotechnology companies are looking to treat symptoms for various conditions, Autonomix Medical Inc. (NASDAQ: AMIX) is going to the root of the issue, which they associate with the PNS. Click here to read more about its revolutionary approach.